Artificial Heart Market By By Product Type (Total Artificial Heart, Ventricular Assist Devices {Left Ventricular Assist Devices, Right Ventricular Assist Devices, Bi-Ventricular Assist Devices}), By Technology (Pneumatic Artificial Heart, Electro-hydraulic Artificial Heart, Magnetic Levitation Artificial Heart), By Application (Bridge to Transplant, Destination Therapy, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Research Institutes, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

Report Coverage:

By Product Type

• Total Artificial Heart
• Ventricular Assist Devices
  • Left Ventricular Assist Devices
  • Right Ventricular Assist Devices
  • Bi-Ventricular Assist Devices

By Technology

• Pneumatic Artificial Heart
• Electro-hydraulic Artificial Heart
• Magnetic Levitation Artificial Heart

By Application

• Bridge to Transplant
• Destination Therapy
• Others

By End-User

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Research Institutes
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• SynCardia Systems LLC
• Abbott Laboratories
• Medtronic plc
• Jarvik Heart, Inc.
• Carmat SA
• BiVACOR Inc.
• Evaheart, Inc.
• ReliantHeart Inc.
• Berlin Heart GmbH
• Abiomed, Inc.
• Calon Cardio-Technology Ltd
• FineHeart SA
• CorWave SA
• CH Biomedical, Inc.
• Cirtec Medical Systems